These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

539 related items for PubMed ID: 19100435

  • 1. Sirolimus-based immunosuppression therapy in liver transplantation for patients with hepatocellular carcinoma exceeding the Milan criteria.
    Zhou J, Wang Z, Wu ZQ, Qiu SJ, Yu Y, Huang XW, Tang ZY, Fan J.
    Transplant Proc; 2008 Dec; 40(10):3548-53. PubMed ID: 19100435
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Sirolimus therapy in liver transplant patients: an initial experience at a single center.
    Nocera A, Andorno E, Tagliamacco A, Morelli N, Bottino G, Ravazzoni F, Casaccia M, Barocci S, Alice S, Santori G, Ghirelli R, Valente U.
    Transplant Proc; 2008 Dec; 40(6):1950-2. PubMed ID: 18675098
    [Abstract] [Full Text] [Related]

  • 4. Multifocal manifestation does not affect vascular invasion of hepatocellular carcinoma: implications for patient selection in liver transplantation.
    Löhe F, Angele MK, Rentsch M, Graeb C, Gerbes A, Löhrs U, Beuers U, Jauch KW.
    Clin Transplant; 2007 Dec; 21(6):696-701. PubMed ID: 17988261
    [Abstract] [Full Text] [Related]

  • 5. Liver transplantation for hepatocellular carcinoma: results of a multicenter study with common priorization criteria.
    Santoyo J, Sanchez B, de la Mata M, Fernández-Aguilar JL, Lopez-Ciller P, Pascasio JM, Suarez MA, Gomez MA, Nogueras F, Muffak K, Cuende N, Alonso M.
    Transplant Proc; 2009 Apr; 41(3):1009-11. PubMed ID: 19376412
    [Abstract] [Full Text] [Related]

  • 6. De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: long-term outcomes and side effects.
    Toso C, Meeberg GA, Bigam DL, Oberholzer J, Shapiro AM, Gutfreund K, Ma MM, Mason AL, Wong WW, Bain VG, Kneteman NM.
    Transplantation; 2007 May 15; 83(9):1162-8. PubMed ID: 17496530
    [Abstract] [Full Text] [Related]

  • 7. Effect of different immunosuppressive schedules on recurrence-free survival after liver transplantation for hepatocellular carcinoma.
    Vivarelli M, Dazzi A, Zanello M, Cucchetti A, Cescon M, Ravaioli M, Del Gaudio M, Lauro A, Grazi GL, Pinna AD.
    Transplantation; 2010 Jan 27; 89(2):227-31. PubMed ID: 20098287
    [Abstract] [Full Text] [Related]

  • 8. Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study.
    Leung JY, Zhu AX, Gordon FD, Pratt DS, Mithoefer A, Garrigan K, Terella A, Hertl M, Cosimi AB, Chung RT.
    Liver Transpl; 2004 Nov 27; 10(11):1343-54. PubMed ID: 15497158
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation.
    Facciuto ME, Koneru B, Rocca JP, Wolf DC, Kim-Schluger L, Visintainer P, Klein KM, Chun H, Marvin M, Rozenblit G, Rodriguez-Davalos M, Sheiner PA.
    Ann Surg Oncol; 2008 May 27; 15(5):1383-91. PubMed ID: 18320284
    [Abstract] [Full Text] [Related]

  • 11. Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence.
    Parfitt JR, Marotta P, Alghamdi M, Wall W, Khakhar A, Suskin NG, Quan D, McAllister V, Ghent C, Levstik M, McLean C, Chakrabarti S, Garcia B, Driman DK.
    Liver Transpl; 2007 Apr 27; 13(4):543-51. PubMed ID: 17394152
    [Abstract] [Full Text] [Related]

  • 12. Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma.
    Zimmerman MA, Trotter JF, Wachs M, Bak T, Campsen J, Skibba A, Kam I.
    Liver Transpl; 2008 May 27; 14(5):633-8. PubMed ID: 18324656
    [Abstract] [Full Text] [Related]

  • 13. Indications and management of everolimus after liver transplantation.
    Bilbao I, Sapisochin G, Dopazo C, Lazaro JL, Pou L, Castells L, Caralt M, Blanco L, Gantxegi A, Margarit C, Charco R.
    Transplant Proc; 2009 May 27; 41(6):2172-6. PubMed ID: 19715864
    [Abstract] [Full Text] [Related]

  • 14. [A retrospective cohort study regarding the effect of sirolimus-based immunosuppression protocol on the long-term survival of hepatocellular carcinoma patients after liver transplantation].
    Zhao X, Lu S, Wang M, Wu J, Lin D, Guo Q, Lai W, Zeng D, Li C, Liu Y, Sun L, Yan D, Li N.
    Zhonghua Wai Ke Za Zhi; 2014 Apr 27; 52(4):245-8. PubMed ID: 24924566
    [Abstract] [Full Text] [Related]

  • 15. Sirolimus monotherapy in liver transplantation.
    Di Benedetto F, Di Sandro S, De Ruvo N, Masetti M, Montalti R, Romano A, Guerrini GP, Ballarin R, De Blasiis MG, Gerunda GE.
    Transplant Proc; 2007 Apr 27; 39(6):1930-2. PubMed ID: 17692656
    [Abstract] [Full Text] [Related]

  • 16. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
    Bozorgzadeh A, Orloff M, Abt P, Tsoulfas G, Younan D, Kashyap R, Jain A, Mantry P, Maliakkal B, Khorana A, Schwartz S.
    Liver Transpl; 2007 Jun 27; 13(6):807-13. PubMed ID: 17539001
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation.
    Tamura S, Kato T, Berho M, Misiakos EP, O'Brien C, Reddy KR, Nery JR, Burke GW, Schiff ER, Miller J, Tzakis AG.
    Arch Surg; 2001 Jan 27; 136(1):25-30; discussion 31. PubMed ID: 11146770
    [Abstract] [Full Text] [Related]

  • 19. Predictors of long-term outcome following liver transplantation for hepatocellular carcinoma: a single-center experience.
    Zimmerman MA, Trotter JF, Wachs M, Bak T, Campsen J, Wright F, Steinberg T, Bennett W, Kam I.
    Transpl Int; 2007 Sep 27; 20(9):747-53. PubMed ID: 17565579
    [Abstract] [Full Text] [Related]

  • 20. Liver transplantation for hepatocellular carcinoma in patients who do not meet the Milan criteria.
    Suh KS, Cho EH, Lee HW, Shin WY, Yi NJ, Lee KU.
    Dig Dis; 2007 Sep 27; 25(4):329-33. PubMed ID: 17960068
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.